Učitavanje...
Lamivudine resistance in children with chronic hepatitis B
Currently, although lamivudine (LAM) has a low genetic barrier, only interferon-alpha and LAM are available as a first-line treatment in children with chronic hepatitis B (CHB). LAM is a potent inhibitor of hepatitis B virus-deoxyribonucleic acid (HBV-DNA) polymerase replication by termination of th...
Spremljeno u:
| Izdano u: | World J Hepatol |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Baishideng Publishing Group Inc
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4411531/ https://ncbi.nlm.nih.gov/pubmed/25937866 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i6.896 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|